Other studies based on DNA methylation profiles demonstrated that the three distinct molecular subgroups (ATRT-TYR, ATRT-SHH, and ATRT-MYC) differ in terms of age at diagnosis, tumor location, type of SMARCB1 alterations, and overall survival. The gene discussed is SHH; the disease is neoplasm.